Future Tools and Treatment Options for Catheter Ablation of Ventricular Tachycardia/Ventricular Fibrillation

Author(s):  
Douglas L. Packer ◽  
Mauricio Scanavacca ◽  
Christian de Chillou ◽  
Sabine Ernst ◽  
Hiroshi Nakagawa
2013 ◽  
pp. 577-589
Author(s):  
Frédéric Sacher ◽  
Mélèze Hocini ◽  
Sébastien Knecht ◽  
Nicolas Derval ◽  
Pierre Jaïs ◽  
...  

ESC CardioMed ◽  
2018 ◽  
pp. 2288-2293
Author(s):  
Victor Bazan ◽  
Enrique Rodriguez-Font ◽  
Francis E. Marchlinski

Patients with ventricular arrhythmias (VAs) and without underlying structural heart disease or baseline electrical disorders (‘idiopathic’ VAs) usually have a benign clinical course. Only rarely do these benign arrhythmias trigger polymorphic ventricular tachycardia and idiopathic ventricular fibrillation. Due to their focal origin and to the absence of underlying myocardial scar, the 12-lead electrocardiogram (ECG) very precisely establishes the right or left ventricular site of origin of the arrhythmia and can help regionalize the origin of ventricular tachycardia for ablation. A 12-lead ECG obtained during the baseline rhythm and 24 h ECG Holter monitoring are indicated in order to identify structural or electrical disorders leading to polymorphic ventricular tachycardia/ventricular fibrillation and to determine the VA burden. The most frequent origin of idiopathic VAs is the right ventricular outflow tract. Other origins include the left ventricular outflow tract, the left ventricular fascicles (fascicular ventricular tachycardias), the left and right ventricular papillary muscles, the crux cordis, the mitral and tricuspid annuli, and the right ventricular moderator band. Recognizing the typical anatomic sites of origin combined with a 12-lead ECG assessment facilitates localization. Antiarrhythmic drug therapy (including use of beta blockers) or catheter ablation may be indicated to suppress or eliminate idiopathic VAs, particularly if there are severe arrhythmia-related symptoms or if the arrhythmia burden is high and ‘tachycardia’-induced cardiomyopathy is suspected. Catheter ablation is frequently preferred to prevent lifelong drug therapy in young patients.


2021 ◽  
Author(s):  
Michael C. Y. Nam ◽  
Nikki Jones ◽  
Simon Claridge ◽  
Richard Balasubramaniam ◽  
Mark Sopher ◽  
...  

2013 ◽  
Vol 2 (2) ◽  
pp. 135 ◽  
Author(s):  
Josef Kautzner ◽  
Petr Peichl ◽  
◽  

Recently, catheter ablation (CA) has become a therapeutic option to target focal triggers of polymorphic ventricular tachycardia and ventricular fibrillation (VF) in the setting of electrical storm (ES). This strategy was first described in subjects without organic heart disease (i.e. idiopathic VF) and subsequently in other conditions, especially in patients with ischaemic heart disease. In the majority of cases, the triggering focus originates in the ventricular Purkinje system. In patients with Brugada syndrome, besides ablation of focal trigger in the right ventricular outflow tract, modification of a substrate in this region has been described to prevent recurrences of VF. In conclusion, CA appears to be a reasonable strategy for intractable cases of ES due to focally triggered polymorphic ventricular tachycardia and VF. Therefore, early transport of the patient into the experience centre for CA should be considered since the procedure could be in some cases life-saving. Therefore, the awareness of this entity and link to the nearest expert centre are important.


Author(s):  
Alexander Wutzler ◽  
Borris Tiedke ◽  
Mohamed Osman ◽  
Noha Mahrous ◽  
Reinhard Wurm

Ventricular storms and fibrillation are potentially lethal arrhythmias with limited treatment options. Failed catheter ablation is associated with a fourfold maortality increase in this population. Stereotactic body radiotherapy has been proposed as last resort. We report a patient in whom radiotherapy was safely performed leading to the elimination of arrhythmias


Sign in / Sign up

Export Citation Format

Share Document